Synthesizing Diagnostic Technology, Adherence Methodologies, and Research To Prevent and Treat Epidemic Chronic Diseases
Apollo Health is building the first ever community around the prevention and reversal of cognitive decline. The foundation of our efforts is a true vision to build communities that support our participants throughout their journeys by providing them with the resources and guides they need to be successful. The community encompasses a professional care team of support staff that works with our participants on the One-time ReCODE Report, the ReVERSE program, and the Bredesen Protocol.
The ReCODE Report, a proprietary implementation of the Bredesen Protocol, allows practitioners and individuals to achieve unprecedented success in the prevention and reversal of cognitive decline. Through genetics, blood biomarkers, and a multi-modal reporting system, participants and their practitioners receive new prevention and treatment options for early-stage Alzheimer’s disease. Our goal is to reduce the global burden of dementia.
The Bredesen Protocol developed by Dr. Dale Bredesen is a comprehensive, personalized program to improve cognition and reverse the cognitive decline of subjective cognitive impairment (SCI), mild cognitive impairment (MCI), and early Alzheimer’s disease. Dr. Bredesen has outlined 36 metabolic factors that can trigger “downsizing” in the brain. Working with the results from the One-time ReCODE Report, the protocol shows us how to rebalance these factors using lifestyle modifications and a community of professionals.
The ReVERSE Program is designed for individuals who would like more resources to combat cognitive decline or the onset of cognitive decline. The program is derived from the principles of the Bredesen Protocol. Utilizing Apollo Health’s One-time ReCODE Report and Dr. Bredesen’s 30+ years of research, we can provide better and more precise outcomes of care, paired with our community of ReCODE certified community of practitioners, specialists, health coaches, and nutritionists.
82% of seniors say it is important to have their thinking or memory checked, but only 16% say they receive regular cognitive assessments. It is startling that more than half of the 5.4 million Americans with the disease have no idea they do. Take the next step to improving your mental health and get a ReCODE Report.
There are 75 million Americans with ApoE4, the most important genetic risk factor for Alzheimer’s disease.
It is expected that by 2050, there will be over 160,000,000 patients with Alzheimer’s disease globally.
In the United States alone, over five million people suffer from Alzheimer’s disease, at an estimated annual cost of $200 billion, and a projection for 13 million patients by 2050.
Apollo Health brings together some of the world’s top experts to help you and your family live better, more healthy lives. Learn about this dedicated team on our leadership page.
In the Media
We’re on the cutting edge of innovation in the field of Alzheimer’s research, prevention, and treatment. Learn more news about our company and our mission on our media page.